AstraZeneca Prilosec DTC Ad Spending Projected To Reach $70 Mil. In 1999
AstraZeneca's Prilosec direct-to-consumer advertising spending is expected to reach $70 mil. for the year, the market research firm Scott-Levin projects.
You may also be interested in...
AstraZeneca's NDA for the Prilosec follow-on product Nexium includes an indication for "on demand" maintenance treatment for gastroesophageal reflux disease.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011